Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Samabriva

Samabriva
2011 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
PE Growth LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Developer of protein based pathogens for medical treatments. The company develops endotoxins or human pathogens free plant root-based expression system to secrete complex recombinant proteins useful for the treatment of rare diseases such as lysosomal diseases.

Formerly Known As
Root Lines Technology
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Primary Office
  • 72 rue des Jacobins
  • 80000 Amiens
  • France

+33 03 00 00 00 00

Samabriva Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Samabriva‘s full profile, request access.

Request full access to PitchBook

Samabriva Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Samabriva‘s full profile, request access.

Request full access to PitchBook

Samabriva Executive Team (2)

Name Title Board
Seat
Contact
Info
Marina Guillet Ph.D Chief Executive Officer
Alain Huriez Chairman & Co-Founder

Samabriva Board Members (1)

Name Representing Role Since Contact
Info
00000 000000 Samabriva Chairman & Co-Founder 000 0000